The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke "ALbumin"


Phase 2 Results N/A

Summary of Purpose

In this clinical study, the efficacy and safety of ALbumin is to be evaluated for the patients occurred within 12 hours of acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 November 2013.

1 Sep 2012 21 Aug 2012 1 Sep 2014 1 Sep 2014 1 Nov 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment